Checkmate Pharmaceuticals, Inc. of CAMBRIDGE, MA, a company, filed a Form D amendment with the SEC on 2019-04-01. The offering totals $22.0M, of which $22.0M was reported sold. Industry: Biotechnology.
Showing 25 of 44 people.
| Name | Role | Location |
|---|---|---|
| Chuck Abdalian | Related Person | Cambridge, MA |
| Ben Auspitz | Related Person | Cambridge, MA |
| Karen Brennan | Related Person | Cambridge, MA |
| Corey Goodman | Related Person | Cambridge, MA |
| Art Krieg | Related Person | Cambridge, MA |
| Barry Labinger | Related Person | Cambridge, MA |
| David Mauro | Related Person | Cambridge, MA |
| Michael Powell | Related Person | Cambridge, MA |
| Charles Yon | Related Person | Cambridge, MA |
| Peter Colabuono | Director | Belmont, CA |
| Robert Weisskoff | Director | Foster City, CA |
| Keith Flaherty | Director | Boston, MA |
| Ben Auspitz | Director | Cambridge, MA |
| Corey Goodman | Director | Cambridge, MA |
| Alan Fuhrman | Director | Carlsbad, CA |
| James Wooldridge | Executive Officer | Cambridge, MA |
| Karen Brennan | Executive Officer | Cambridge, MA |
| Kleem Chaudhary | Executive Officer | BURLINGTON, MA |
| Jonathan Lieber | Executive Officer | Cambridge, MA |
| Michael Powell | Director | Cambridge, MA |
| Barry Labinger | Director | Cambridge, MA |
| Barry Labinger | Executive Officer | Cambridge, MA |
| Charles Yon | Executive Officer | Cambridge, MA |
| Arthur Krieg | Director | Cambridge, MA |
| Arthur Krieg | Executive Officer | Cambridge, MA |
| Filed | Form | Offering | Sold |
|---|---|---|---|
| 2020-06-18 | D | $100.1M | $85.1M |
| 2020-04-24 | D | $10.0M | $10.0M |
| 2020-01-28 | D/A | $16.0M | $16.0M |
| 2019-08-20 | D | $16.0M | $8.0M |
| 2018-12-12 | D | $22.0M | $11.0M |
| 2017-06-16 | D | $27.0M | $27.0M |
| 2017-02-16 | D/A | $25.0M | $25.0M |
| 2016-06-30 | D/A | $20.0M | $20.0M |
| 2015-08-25 | D | $20.0M | $10.0M |